Is bimekizumab effective for patients who have failed an IL-17 blocker?
Featuring April Armstrong, MD, MPH | Co-Director |
Chief, Division of Dermatology
David Geffen School of Medicine at UCLA
Los Angeles, CA
Related Media
Powered by Polaris TMFeaturing April Armstrong, MD, MPH | Co-Director |
Chief, Division of Dermatology
David Geffen School of Medicine at UCLA
Los Angeles, CA
Related Media
Powered by Polaris TM